Abstract
Acceptable antifertility drugs for men are proving difficult to produce. Such drugs must aim to achieve complete azoospermia over a long period. This requirement may be relaxed only if it can be shown that the residual sperm produced by men whose spermatogenesis has been suppressed by antifertility drugs to oligospermia are incapable of fertilizing ova. Hormonal methods involving suppression of the secretion of gonadotrophin hormones by the pituitary gland invariably require androgen supplementation, and the use of steroids either alone or in combination requires careful monitoring for their side-effects. A chemical (non-hormonal) approach involving the incapacitation of sperm in the epididymis has been shown to be feasible in animal studies using α-chlorohydrin and 6-chloro-6-deoxy sugars, although such compounds cannot be developed for human use because of their toxicity. Immunological approaches have the inherent problem of delivery of the antibody to the target. While the search for new and safer chemical and hormonal approaches goes on, the recent evidence that vasectomy offers a safe surgical option leaves responsible men with some choice to add to the condom.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Delanoe D., Fougeyrollas B., Meyer L., Thonneau P. Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception. Lancet. 1984 Feb 4;1(8371):276–276. doi: 10.1016/s0140-6736(84)90144-2. [DOI] [PubMed] [Google Scholar]
- Franchimont P., Verstraelen-Proyard J., Hazee-Hagelstein M. T., Renard C., Demoulin A., Bourguignon J. P., Hustin J. Inhibin: from concept to reality. Vitam Horm. 1979;37:243–302. doi: 10.1016/s0083-6729(08)61071-7. [DOI] [PubMed] [Google Scholar]
- Mason A. J., Hayflick J. S., Ling N., Esch F., Ueno N., Ying S. Y., Guillemin R., Niall H., Seeburg P. H. Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature. 1985 Dec 19;318(6047):659–663. doi: 10.1038/318659a0. [DOI] [PubMed] [Google Scholar]
- Massey F. J., Jr, Bernstein G. S., O'Fallon W. M., Schuman L. M., Coulson A. H., Crozier R., Mandel J. S., Benjamin R. B., Berendes H. W., Chang P. C. Vasectomy and health. Results from a large cohort study. JAMA. 1984 Aug 24;252(8):1023–1029. doi: 10.1001/jama.252.8.1023. [DOI] [PubMed] [Google Scholar]
- Qian S. Z., Wang Z. G. Gossypol: a potential antifertility agent for males. Annu Rev Pharmacol Toxicol. 1984;24:329–360. doi: 10.1146/annurev.pa.24.040184.001553. [DOI] [PubMed] [Google Scholar]
- Schürmeyer T., Knuth U. A., Freischem C. W., Sandow J., Akhtar F. B., Nieschlag E. Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion. J Clin Endocrinol Metab. 1984 Jul;59(1):19–24. doi: 10.1210/jcem-59-1-19. [DOI] [PubMed] [Google Scholar]
- Srinath B. R., Wickings E. J., Witting C., Nieschlag E. Active immunization with follicle-stimulating hormone for fertility control: a 4 1/2-year study in male rhesus monkeys. Fertil Steril. 1983 Jul;40(1):110–117. doi: 10.1016/s0015-0282(16)47187-6. [DOI] [PubMed] [Google Scholar]
- Weinbauer G. F., Surmann F. J., Akhtar F. B., Shah G. V., Vickery B. H., Nieschlag E. Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis). Fertil Steril. 1984 Dec;42(6):906–914. doi: 10.1016/s0015-0282(16)48264-6. [DOI] [PubMed] [Google Scholar]
- de Jong F. H., Robertson D. M. Inhibin: 1985 update on action and purification. Mol Cell Endocrinol. 1985 Sep;42(2):95–103. doi: 10.1016/0303-7207(85)90096-6. [DOI] [PubMed] [Google Scholar]